Friday, July 10, 2026

pharma · CXCR4 · Uterine Cervical Neoplasms

Zhongnan Hospital

Zhongnan Hospital trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.

CN HQ
NMPA registrant Type
Company details
Status
Public
HQ
CN
Programs
2
Drugs
5
Patents
0
Intelligence · Clinical Trials

Zhongnan Hospital clinical trials

Registry index of 2 ClinicalTrials.gov studies linked to Zhongnan Hospital programs — each row shows trial ID, program name, phase, status, and indication.

Zhongnan Hospital trial registry — 2 ClinicalTrials.gov studies with program phase, status, and indication context.

Recent trial activity

2 updates

Latest clinical program signals indexed for Zhongnan Hospital.

  1. Hydrochloride anlotinib — Unknown

    Clinical update
  2. 68Ga-pentixafor — Unknown

    Clinical update

Trial registry

2 studies